Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Teicher

Showing results (41-50 of 417) with videos related to

Pageof 42
Sort By:
Harefuah|June 1, 1982
[Sympathetic nervous system and hypertension]A Teicher, T Rosenthal
Current Pharmaceutical Design|July 27, 2001
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptidesC Shih, B A Teicher
Investigational New Drugs|January 1, 1997
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsY Kakeji, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1988
Development of alkylating agent-resistant human tumor cell linesB A Teicher, E Frei
Journal of Clinical Psychology|October 29, 2010
A clinical approach to reporting psychological test dataJ L TAYLOR, A TEICHER
Biochemical Pharmacology|April 20, 2006
TGF-beta in cancer and as a therapeutic targetJan Pinkas, Beverly A Teicher
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1996
Cyclooxygenase and lipoxygenase inhibitors in cancer therapyG Ara, B A Teicher
Current Cancer Drug Targets|February 25, 2022
Antibody-drug Conjugate Targets, Drugs, and LinkersBeverly A Teicher, Joel Morris
Cancer Treatment and Research|January 1, 1991
Modulation of antitumor alkylating agents (AA)B A Teicher, E Frei
Biochemical Pharmacology|May 4, 2015
Proteasome inhibitorsBeverly A Teicher, Joseph E Tomaszewski
Pageof 42

Showing results (41-50 of 417) with videos related to

Sort By:
Pageof 42
Harefuah|June 1, 1982
[Sympathetic nervous system and hypertension]A Teicher, T Rosenthal
Current Pharmaceutical Design|July 27, 2001
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptidesC Shih, B A Teicher
Investigational New Drugs|January 1, 1997
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsY Kakeji, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1988
Development of alkylating agent-resistant human tumor cell linesB A Teicher, E Frei
Journal of Clinical Psychology|October 29, 2010
A clinical approach to reporting psychological test dataJ L TAYLOR, A TEICHER
Biochemical Pharmacology|April 20, 2006
TGF-beta in cancer and as a therapeutic targetJan Pinkas, Beverly A Teicher
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1996
Cyclooxygenase and lipoxygenase inhibitors in cancer therapyG Ara, B A Teicher
Current Cancer Drug Targets|February 25, 2022
Antibody-drug Conjugate Targets, Drugs, and LinkersBeverly A Teicher, Joel Morris
Cancer Treatment and Research|January 1, 1991
Modulation of antitumor alkylating agents (AA)B A Teicher, E Frei
Biochemical Pharmacology|May 4, 2015
Proteasome inhibitorsBeverly A Teicher, Joseph E Tomaszewski
Pageof 42